66F1449C3284D81287258C12005C1AB4 Hearing Summary

PUBLIC
BILL SUMMARY For HB25-1063

HOUSE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Jan 14, 2025
Location HCR 0107

HB25-1063 - Referred to the Committee of the Whole

09:46:03 AM

The primary bill
sponsors, Representatives Hartsook and Brown, introduced House Bill 25-1063
to the House Health and Human Services Committee.The bill changes the definition
of psilocybin in Schedule I to exempt prescription drug products containing
crystalline polymorph psilocybin if such prescription drugs are approved
by the U.S. Food and Drug Administration.

09:54:20 AM

The bill sponsors responded to questions from the committee.

09:57:59 AM

Tess Bettler, representing Compass Pathways, testified in support of the bill.

10:00:54 AM

Ms. Bettler responded to questions from the committee.

10:03:06 AM

Mr. Jimmy Smrz, representing themself, testified in opposition to the bill.

10:06:41 AM

Mr. Smrz responded to questions from the committee.

10:11:47 AM

John Armstrong -
fiscal analyst, representing the Legislative Council Staff, responded to
questions from members of the committee.

10:15:26 AM

The primary bill
sponsors provided closing comments on the bill.

10:18:29 AM

Members of the committee provided closing comments on the bill.

10:22:55 AM	Motion	Refer House Bill 25-1063 to the Committee of the Whole.
	Moved	Brown
	Seconded	Rydin

	Bradfield	Yes
	Bradley	No
	Feret	Yes
	Gilchrist	Yes
	Hamrick	Yes
	Johnson	Yes
	Lukens	Yes
	McCormick	Yes
	Rydin	Yes
	Sander	Yes
	Stewart K.	Yes
	Lieder	Yes
	Brown	Yes
	Final	YES: 12 NO: 1 EXC: 0 ABS: 0 FINAL ACTION: PASS

HB25-1063 - Referred to the Committee of the Whole

Colorado General Assembly